Rezipas en es it fr

Rezipas Brand names, Rezipas Analogs

Rezipas Brand Names Mixture

  • No information avaliable

Rezipas Chemical_Formula


Rezipas RX_link

Rezipas fda sheet

Rezipas msds (material safety sheet)

Rezipas MSDS

Rezipas Synthesis Reference

Biniecki S., et al. Acta Pol Pharm. 1967;24(5):469-73

Rezipas Molecular Weight

153.135 g/mol

Rezipas Melting Point

150.5 oC

Rezipas H2O Solubility

1690 mg/L

Rezipas State


Rezipas LogP


Rezipas Dosage Forms

Packet of coated granules

Rezipas Indication

For the treatment of tuberculosis

Rezipas Pharmacology

Aminosalicylic acid is an anti-mycobacterial agent used with other anti-tuberculosis drugs (most often isoniazid) for the treatment of all forms of active tuberculosis due to susceptible strains of tubercle bacilli. The two major considerations in the clinical pharmacology of aminosalicylic acid are the prompt production of a toxic inactive metabolite under acid conditions and the short serum half life of one hour for the free drug. Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis (prevents the multiplying of bacteria without destroying them). It also inhibits the onset of bacterial resistance to streptomycin and isoniazid.

Rezipas Absorption

No information avaliable

Rezipas side effects and Toxicity

LD50=4 gm/kg (orally in mice); LD50=3650 mg/kg (orally in rabbits)

Rezipas Patient Information

Rezipas Organisms Affected